PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1454242
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1454242
Global alginate dressing market was valued US$ 809.9 Mn in 2023 and is expected to reach US$ 1,129.4 Mn by 2031 exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2023/2024: | US$ 809.9 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 - 2031 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 4.20% | 2030/2031 Value Projection: | US$ 1,129.4 Mn |
Alginate dressings are a type of wound dressing that is particularly suited for wounds with a significant amount of exudate, which are fluids that seep out of wounds, often seen in pressure ulcers, venous ulcers, or diabetic foot ulcers. These dressings consist of natural polysaccharide fibers that are derived from brown seaweed, which are known for their highly absorbent properties. When alginate fibers come in contact with wound exudate, they absorb the liquid and form a gel, thereby providing a moist environment conducive to wound healing and tissue regeneration. The benefits of using alginate dressings include their biodegradability, ease of removal, hemostatic properties (they can help to control minor bleeding), and their ability to maintain a moist healing environment. The gelling action of alginates can also assist in debriding the wound as the gel can lift and trap dead tissue, thus promoting a cleaner wound bed. In clinical practice, alginate dressings are often used for packing deep, cavernous wounds, managing infected wounds, or treating wounds that are at risk of infection due to their antimicrobial properties when combined with substances such as silver. They are not suitable for dry wounds or those with minimal exudate, as they can dry out and adhere to the wound bed, thereby causing trauma upon removal. Healthcare professionals choose alginate dressings for their versatility and efficacy, especially in the critical phases of wound management. It is important to select the appropriate dressing type for each unique wound, and alginates play a significant role within the array of options available.
Global alginate dressing market is driven by the rising geriatric population who are more prone to chronic wounds, growing prevalence of diabetes leading to diabetic foot ulcers, and increasing incidence of burns and traumatic injuries. However, high costs that are associated with advanced wound dressings are a major factor restraining the market growth. Development of new product formulations that can remain in place for longer durations without requiring frequent dressing changes presents lucrative opportunities for manufacturers.